1. Home
  2. BEAM vs WSBC Comparison

BEAM vs WSBC Comparison

Compare BEAM & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • WSBC
  • Stock Information
  • Founded
  • BEAM 2017
  • WSBC 1870
  • Country
  • BEAM United States
  • WSBC United States
  • Employees
  • BEAM N/A
  • WSBC N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • WSBC Major Banks
  • Sector
  • BEAM Health Care
  • WSBC Finance
  • Exchange
  • BEAM Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • BEAM 2.3B
  • WSBC 2.4B
  • IPO Year
  • BEAM 2020
  • WSBC N/A
  • Fundamental
  • Price
  • BEAM $30.43
  • WSBC $35.41
  • Analyst Decision
  • BEAM Buy
  • WSBC Buy
  • Analyst Count
  • BEAM 10
  • WSBC 5
  • Target Price
  • BEAM $48.75
  • WSBC $41.40
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • WSBC 502.6K
  • Earning Date
  • BEAM 03-04-2025
  • WSBC 01-22-2025
  • Dividend Yield
  • BEAM N/A
  • WSBC 4.16%
  • EPS Growth
  • BEAM N/A
  • WSBC N/A
  • EPS
  • BEAM N/A
  • WSBC 2.26
  • Revenue
  • BEAM $349,643,000.00
  • WSBC $586,985,000.00
  • Revenue This Year
  • BEAM N/A
  • WSBC N/A
  • Revenue Next Year
  • BEAM $14.62
  • WSBC $11.64
  • P/E Ratio
  • BEAM N/A
  • WSBC $15.76
  • Revenue Growth
  • BEAM 328.73
  • WSBC 0.50
  • 52 Week Low
  • BEAM $20.84
  • WSBC $25.56
  • 52 Week High
  • BEAM $49.50
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 57.12
  • WSBC 52.27
  • Support Level
  • BEAM $25.35
  • WSBC $36.17
  • Resistance Level
  • BEAM $35.25
  • WSBC $37.18
  • Average True Range (ATR)
  • BEAM 2.10
  • WSBC 0.86
  • MACD
  • BEAM 0.56
  • WSBC -0.05
  • Stochastic Oscillator
  • BEAM 55.88
  • WSBC 45.87

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.

Share on Social Networks: